Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase NA 5Phase 2 3Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3NETWORK 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Other neoplasm 1

Conditions

Stomach Neoplasms 2Gastric Adenocarcinoma 1

Interventions

Cisplatin 1038Cyclophosphamide 972Carboplatin 952Radiotherapy 890Bevacizumab 845Gemcitabine 817pembrolizumab 758Paclitaxel 738Docetaxel 733Oxaliplatin 704Capecitabine 646Fluorouracil 563Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 400Leucovorin 376Cytarabine 342Cetuximab 338Lenalidomide 326Trastuzumab 321Pemetrexed 314durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 277Temozolomide 275Prednisone 273

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Gastrectomy × Clear all
NCT05753306 2026-04-08

Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

Mayo Clinic

Phase 2 Recruiting
40 enrolled
GastrointestinalOther neoplasm

Gastric Adenocarcinoma

NCT02931890 2024-05-02

CRITICS-II

The Netherlands Cancer Institute

Phase 2 Active not recruiting
207 enrolled
Gastrointestinal

Stomach Neoplasms

NCT04782791 2022-01-11

Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric Cancer

Chinese PLA General Hospital

Phase 2 Unknown
30 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡